Académique Documents
Professionnel Documents
Culture Documents
Melissa C. Martin, M.S., FACR, FACMP American College of Medical Physics 21st Annual Meeting & Workshops Scottsdale, AZ June 13, 2004
NCRP Report 49
Primary and secondary barrier calculation methodology Applicable up to 60Cobalt and linacs up to 10 MV
NCRP Report 51
Extended NCRP 49 methodology up to 100 MV Empirical shielding requirements for maze doors
NCRP Report 79
Improved neutron shielding methodology
Reports reflect progress in linac design and shielding research Reports reflect progress in linac design and shielding research
Revised NCRP Report in Drafting Stage by AAPM Task Group 57, NCRP SC 46-13
s
s s s s
Calculation scheme generally follows NCRP 49 All shielding data (TVLs) reviewed and updated Updated for intensity modulated radiation therapy (IMRT) Improved accuracy of entrance requirements
Both with and without the use of maze
NCRP 116 dose limit is a factor of 5 lower than NCRP 49 value NCRP 116 dose limit is a factor of 5 lower than NCRP 49 value
Permissible dose outside vault depends on occupancy Occupancy factor (T): Fraction of time a particular location may be occupied Maximum shielded dose (Smax) at protected location
S max =
P T
Maximum shielded dose is traditionally referred to simply as P/T Maximum shielded dose is traditionally referred to simply as P/T
Full occupancy for controlled areas by convention (T=1) Full occupancy uncontrolled areas (T=1)
Offices, laboratories, shops, wards, nurses stations, living quarters, childrens play areas, and occupied space in nearby buildings
0.02 mSv hourly limit for uncontrolled areas 20 Gy/hr common assumption for calculation Implies a lower limit for occupancy factor
T 20 / ( U W ) T 0.16 for higher energy accelerators (500 Gy / wk workload) T 0.08 for lower energy accelerators (1000 Gy wk workload)
T = 1/10 rather than 1/16 typically used for exterior walls T = 1/10 rather than 1/16 typically used for exterior walls
Impact increases if higher occupancy than T=1/40 adopted Impact increases if higher occupancy than T=1/40 adopted
S pri
s
WU 2 d pri
A'
n =
s
M aze
*
tC C
T arget Is o c e n te r
p ri
C'
tC =
1 ft
Margin in primary barrier thickness is recommended to Margin in primary barrier thickness is recommended to compensate for potential concrete density variation compensate for potential concrete density variation
Primary Barrier Photon Tenth-Value Layers (mm) Come from a Variety of Sources
MV 0.2 0.25 0.3 0.4 0.5 1 2 4 6 10 15 18 20 24 Lead TVL1 TVLe 1.7 1.7 2.9 2.9 4.8 4.8 8.3 8.3 11.9 11.9 26 26 42 42 53 53 56 56 56 56 56 56 56 56 56 56 56 56 NCRP 51 Concrete TVL1 TVLe 84 84 94 94 104 104 109 109 117 117 147 147 210 210 292 292 367 323 410 377 445 416 462 432 470 442 483 457 Steel TVL1 TVLe 15 15 19 19 22 22 29 29 33 33 54 51 76 69 91 91 100 100 104 104 108 108 109 109 110 110 110 110 Earth TVL1 TVLe 135 135 151 151 167 167 175 175 188 188 236 236 336 336 468 468 572 572 648 648 720 720 740 740 752 752 773 773 Borated Poly TVL1 TVLe 84 84 94 94 104 104 109 109 117 117 147 147 210 210 292 292 343 343 379 379 379 379 379 379 390 390 401 401
NCRP 49
McGinley
Anticipate upcoming NCRP report to review and update TVL data Anticipate upcoming NCRP report to review and update TVL data
wC =
s
T a r g e t to N a r r o w P o in t D is t a n c e ( d C ')
*
w C
C
T a rg e t Is o c e n te r
T a r g e t to N a r r o w P o in t D is t a n c e ( d C ')
*
w C
C
T a rg e t Is o c e n te r
T a r g e t to N a r r o w P o in t D is t a n c e ( d C ')
T a rg e t Is o c e n te r
1 ft
1 ft
1 ft
M e ta l
1 ft
C'
1 ft
C'
1 ft
Slant Factor
Path from target to protected location diagonally through barrier Incident angle of line with respect to perpendicular Required barrier thickness reduced by cos( ) Same total distance through barrier to protected location
Recent safety survey indicated somewhat higher 3.8 x 10-4 value for steel at 18 MV is appropriate
N adjusted versus MV based on neutron leakage fraction vs MV F is field size (conventionally 0.16 m2), t2 is metal thickness (m) X-Ray attenuation prior to metal layer: 10^(-t1 / TVLp) Neutron attenuation after metal layer: 10^(-t3 / TVLN)
Metal in primary barrier can increase patient total body dose if MV > 10
Lead inside layer approximately doubles patient total body dose Increases risk of secondary cancer
Impact of IMRT on patient photonuclear dose is addressed later Avoid metal as inside layer of primary barrier if MV > 10 Avoid metal as inside layer of primary barrier if MV > 10
Secondary Barrier
s
Sp
A'
M aze
sca
*
C
T a rg e t Is o c e n te r
sec
tB 1 ft C'
SL
W 10 2 d sec
Leakage Photon Tenth-Value Layers (mm) Also Come from a Variety of Sources
MV 4 6 10 15 18 20 24
Concrete TVL1 TVLe 292 292 341 284 351 320 361 338 363 343 366 345 371 351
Earth TVL1 TVLe 468 468 546 455 562 512 578 541 581 549 586 552 594 562
Borated Poly TVL1 TVLe 292 292 341 284 351 320 361 338 363 343 366 345 371 351
NCRP 49
Neutron Leakage
s s
Same form as photon leakage calculation Based on dose-equivalent neutron leakage fraction vs MV
0.002%, 0.04%, 0.10%, 0.15% and 0.20% for 10, 15, 18, 20 and 24 MV Based on Varian and Siemens neutron leakage data Assumes quality factor of 10 for absorbed dose
Neutrons dominate patient total body dose for high energy linacs
Neutron dose equivalent as high as ten times photon dose Potentially 1% of workload vs 0.1% photon leakage
s
Typical neutron dose equivalent is lower than requirement 0.1 to 0.2% of workload
s
Most IMRT is performed at 6 MV to mitigate increased secondary Most IMRT is performed at 6 MV to mitigate increased secondary cancer risk from photoneutrons cancer risk from photoneutrons
A'
M aze
sca
T a rg e t Is o c e n te r
S c a tte r A n g le
S la n t t h ic k n e s s u s e d t o c a lc u l a t e a tte n u a tio n
sec
C'
A c tu a l b a r r ie r t h ic k n e s s
1 ft
Based on recent simulation work by Taylor et.al. Scatter fraction increases as angle decreases Scatter fraction vs MV may increase or decrease
Tends to increase with MV at small scatter angles Decreases with increasing MV at large scatter angles
MV 4 6 10 15 18 20 24 10 1.04E-02 1.04E-02 1.66E-02 1.51E-02 1.42E-02 1.52E-02 1.73E-02 20 6.73E-03 6.73E-03 5.79E-03 5.54E-03 5.39E-03 5.66E-03 6.19E-03 30 2.77E-03 2.77E-03 3.18E-03 2.77E-03 2.53E-03 2.59E-03 2.71E-03 Angle (degrees) 45 60 2.09E-03 1.24E-03 1.39E-03 8.24E-04 1.35E-03 7.46E-04 1.05E-03 5.45E-04 8.64E-04 4.24E-04 8.54E-04 4.13E-04 8.35E-04 3.91E-04 90 6.39E-04 4.26E-04 3.81E-04 2.61E-04 1.89E-04 1.85E-04 1.76E-04 135 4.50E-04 3.00E-04 3.02E-04 1.91E-04 1.24E-04 1.23E-04 1.21E-04 150 4.31E-04 2.87E-04 2.74E-04 1.78E-04 1.20E-04 1.18E-04 1.14E-04
Ambiguity remains as to TVL to use for scatter Ambiguity remains as to TVL to use for scatter
Goal: More-precise calculation avoiding over or under-shielding Goal: More-precise calculation avoiding over or under-shielding
Unshielded dose
Sp =
s
a W ( F / 400) 0.5 AC 2 2 2 d P1 d P 2 d P 3
D
A'
where
0.5 is 0.5 MV scatter fraction Second bounce fraction 0.02 per m2 typically used Other constants as before, e.g., a = patient scatter fraction F = field size in cm^2 h = room height
d
P3
P1
*
C
T arg et Is o c e n te r
d A w
C
P2
= w
Unshielded dose
SS
where
f W 1 A1 0.5 AM 2 2 2 d S1 d S 2 d S 3
D
A'
S3
*
C
T arg et Is o c e n te r
f = patient transmission 1 = first reflection coefficient 0.005 per m2 for 6 MV 0.004 per m2 for 10 MV
d d
M S2
S1
A1 = beam area (m2) at wall AM = Maze cross section (m2) dM x room height
Unshielded dose
S LS
where
W 10 3 1 AC 2 2 d L1 d L 2
D oor T a rg e t R o ta tio n a l P la n e
A'
D' d
L2
*
C
T arget Is o c e n te r
L1
= w
Unshielded dose
Door
SL
s
W 10 10 2 dL
t D ' / TVL
A tD ' D'
A'
T a rg e t R o ta tio n a l P la n e
d D
Same as standard secondary photon leakage calculation Standard neutron leakage not typically used
Use only if it exceeds the maze neutron calculation e.g., if maze wall not sufficiently thick
*
C
T a rg e t Is o c e n te r
C'
H NT
where
W Ln [1+ ( d N 2 3) / 5 ] 2 d N 1 10
D
A'
N2
*
C
T arget Is o c e n te r
Ln is neutron leakage fraction Same as used for secondary neutron leakage calculation Modification to Kersey is assuming first tenth-value distance is 3 m instead of 5 m
C'
N1
Upcoming NCRP report may recommend a more-complex approach Upcoming NCRP report may recommend a more-complex approach than this than this
Modeled as 50% thermal neutrons and 50% fast neutrons 1 inch borated poly effectively eliminates all thermal neutrons Fast neutron TVL is 2.4 inches for the first 4 inches Fast neutron TVL is 3.6 inches beyond 4 inches thickness
s s
Unshielded dose is a factor of 0.2 to 0.5 of the neutron dose equivalent at the treatment room door
Use the conservative factor (0.5)
Dominates X-Ray dose at maze entrance for high energy linacs Dominates X-Ray dose at maze entrance for high energy linacs
Direct-Shielded Door
s
Steel covers
s
Uses standard secondary barrier calculation Goal: provide same protection as wall or door for path through corner
Is o c e n te r T a rg e t R o ta tio n a l P la n e
N2
T a rg e t R o ta tio n a l P la n e
P ro te c te d P o in t (1 ft b e y o n d door e n c lo s u r e )
s s
Ducts shielded with material similar to the door at entrance Material thickness 1/2 to 1/3 that required of the door
Path through material is at a very oblique angle due to penetration location with slant factor between 2 and 3 Factor of at least 5 reduction in dose at head level (the protected location) vs. at the HVAC duct opening
NCRP 49 recommends that shielding extend at least a factor of three times the width of the HVAC penetration
Photon Skyshine
s
Unshielded dose
S sky =
where
2 m e te r s
Y1
h
Is o c e n te r
Multiplying by additional factor of two is recommended Primary TVLs used to calculate attenuation
*
F lo o r
T a rg e t
h
Y2
New construction seldom shields solely for skyshine due to New construction seldom shields solely for skyshine due to vigilance required to prevent unauthorized roof access vigilance required to prevent unauthorized roof access
Neutron Skyshine
s
Unshielded dose
H sky =
where
5.4 10
H pri
*
F lo o r
T arg et Is o c e n te r
Hpri is neutron dose-eq in beam (0.00013, 0.002, 0.0039, 0.0043, and 0.014 times W for 10, 15, 18, 20, and 24 MV, respectively)
s
U p to 2 0 m e te r s la te r a l d is ta n c e
Use factor is not applied since neutrons in all orientations Multiplying by additional factor of two is recommended
References
s
Biggs, Peter J. Obliquity factors for 60Co and 4, 10, 18 MV X rays for concrete, steel, and lead and angles of incidence between 0 and 70, Health Physics. Vol. 70, No 4, 527-536, 1996. British Journal of Radiology (BJR) Supplement No. 11. Central axis depth dose data for use in radiotherapy, 1972. Chibani, Omar and C.C. Ma. Photonuclear dose calculations for high-energy beams from Siemens and Varian linacs, Medical Physics, Vol 30, No. 8:1990-2000, August 2003. Kleck, J. Radiation therapy facility shielding design. 1998 AAPM Annual Meeting
References (Continued)
s
McGinley, P.H. Shielding Techniques for Radiation Oncology Facilities, 2nd ed. Madison, WI: Medical Physics Publishing, 2002. National Council on Radiation Protection and Measurements. Structural shielding design and evaluation for medical use of x-ray and gamma rays of energies up to 10 MeV. Washington, DC: NCRP, NCRP Report 49, 1976. National Council on Radiation Protection and Measurements. Radiation protection design guidelines for 0.1-100 MeV particle accelerator facilities. Washington, DC: NCRP, NCRP Report 51, 1977.
References (Continued)
s
National Council on Radiation Protection and Measurements. Neutron Contamination from Medical Accelerators. Bethesda, MD: NCRP, NCRP Report 79, 1984. Nelson, W.R., and P.D. LaRiviere. Primary and leakage radiation calculations at 6, 10, and 25 MeV, Health Physics. Vol. 47, No. 6: 811-818, 1984. Rodgers, James E. IMRT Shielding Symposium AAPM Annual Meeting, 2001. Shobe, J., J.E. Rodgers, and P.L. Taylor. Scattered fractions of dose from 6, 10, 18, and 25 MV linear accelerator X rays in radiotherapy facilities, Health Physics, Vol. 76, No. 1, 27-35, 1999.
References (Continued)
s
Taylor, P.L., J.E. Rodgers, and J. Shobe. Scatter fractions from linear accelerators with x-ray energies from 6 to 24 MV," Medical Physics, Vol. 26, No. 8, 1442-46, 1999.